Total Payments
$924,809
2024 Payments
$2,544
Companies
24
Transactions
212
Medicare Patients
309
Medicare Billing
$37,024
Payment Breakdown by Category
Research$911,482 (98.6%)
Consulting$4,450 (0.5%)
Food & Beverage$4,312 (0.5%)
Other$4,099 (0.4%)
Travel$465.97 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $911,482 | 28 | 98.6% |
| Consulting Fee | $4,450 | 1 | 0.5% |
| Food and Beverage | $4,312 | 176 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,099 | 4 | 0.4% |
| Travel and Lodging | $465.97 | 3 | 0.1% |
Payments by Type
Research
$911,482
28 transactions
General
$13,327
184 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $911,966 | 44 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $5,636 | 29 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $4,316 | 15 | $0 (2024) |
| Allergan, Inc. | $906.02 | 55 | $0 (2021) |
| Aerie Pharmaceuticals, Inc. | $430.74 | 12 | $0 (2021) |
| Genentech USA, Inc. | $376.03 | 15 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $239.31 | 2 | $0 (2024) |
| ABBVIE INC. | $226.55 | 9 | $0 (2024) |
| Alcon Laboratories Inc | $102.73 | 1 | $0 (2017) |
| Alcon Vision LLC | $98.76 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,544 | 17 | Regeneron Healthcare Solutions, Inc. ($2,100) |
| 2023 | $2,584 | 26 | Regeneron Healthcare Solutions, Inc. ($2,004) |
| 2022 | $251.82 | 13 | Alcon Vision LLC ($50.88) |
| 2021 | $286.12 | 14 | Aerie Pharmaceuticals, Inc. ($83.04) |
| 2020 | $309.11 | 15 | Allergan, Inc. ($203.58) |
| 2019 | $428,423 | 50 | Shire North American Group Inc ($427,509) |
| 2018 | $484,792 | 50 | Shire North American Group Inc ($484,159) |
| 2017 | $5,618 | 27 | Novartis Pharmaceuticals Corporation ($5,113) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,599.17 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: EYE CARE | ||||||
| 11/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/04/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: EYE CARE | ||||||
| 10/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Ophthalmology | ||||||
| 10/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/25/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: EYE CARE | ||||||
| 09/19/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Ophthalmology | ||||||
| 09/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/10/2024 | Johnson & Johnson Surgical Vision, Inc. | TECNIS IOL (Device) | Food and Beverage | In-kind items and services | $94.29 | General |
| Category: Optics | ||||||
| 09/05/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: OPTOMETRY | ||||||
| 09/04/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $470.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/21/2023 | ABBVIE INC. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: EYE CARE | ||||||
| 12/14/2023 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/26/2023 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: EYE CARE | ||||||
| 10/23/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/28/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $34.91 | General |
| 09/21/2023 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.68 | General |
| Category: EYE CARE | ||||||
| 09/20/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: DRY EYE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-MASKED STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF SHP640 PVP-IODINE 0.6 AND DEXAMETHASONE 0.1 OPHTHALMIC SUSPENSION COMPARED TO PVP-IODINE AND PLACEBO IN THE TREATMENT OF ADENOVIRAL CONJUNCTIVITIS | Shire North American Group Inc | $517,437 | 18 |
| A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-MASKED STUDY TO EVALUATE THE CLINICAL EFFICACY AND SAFETY OF SHP640 PVP-IODINE 0.6 AND DEXAMETHASONE 0.1 OPHTHALMIC SUSPENSION COMPARED TO PLACEBO IN THE TREATMENT OF BACTERIAL CONJUNCTIVITIS | Shire North American Group Inc | $394,044 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 68 | $7,160 | $3,323 |
| 2022 | 2 | 45 | 81 | $9,475 | $4,520 |
| 2021 | 3 | 80 | 147 | $17,610 | $8,475 |
| 2020 | 6 | 137 | 345 | $50,355 | $20,705 |
Total Patients
309
Total Services
641
Medicare Billing
$37,024
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 21 | 29 | $4,785 | $2,396 | 50.1% |
| 92134 | Imaging of retina | Office | 2023 | 26 | 39 | $2,375 | $927.57 | 39.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 23 | 40 | $6,600 | $3,464 | 52.5% |
| 92134 | Imaging of retina | Office | 2022 | 22 | 41 | $2,875 | $1,056 | 36.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 37 | 56 | $8,780 | $5,022 | 57.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 25 | 62 | $5,250 | $1,838 | 35.0% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 18 | 29 | $3,580 | $1,614 | 45.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 46 | 95 | $13,775 | $7,932 | 57.6% |
| 67028 | Injection of drug into eye | Office | 2020 | 18 | 67 | $16,750 | $5,199 | 31.0% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 20 | 44 | $4,180 | $2,727 | 65.3% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 31 | 92 | $9,200 | $2,711 | 29.5% |
| J7999 | Compounded drug, not otherwise classified | Office | 2020 | 11 | 35 | $5,250 | $1,593 | 30.3% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 11 | 12 | $1,200 | $542.30 | 45.2% |
About Dr. Sunir Joshi, M.D
Dr. Sunir Joshi, M.D is a Ophthalmology healthcare provider based in Ft Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659564862.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunir Joshi, M.D has received a total of $924,809 in payments from pharmaceutical and medical device companies, with $2,544 received in 2024. These payments were reported across 212 transactions from 24 companies. The most common payment nature is "" ($911,482).
As a Medicare-enrolled provider, Joshi has provided services to 309 Medicare beneficiaries, totaling 641 services with total Medicare billing of $37,024. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Ft Lauderdale, FL
- Active Since 08/21/2007
- Last Updated 08/07/2014
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1659564862
Products in Payments
- SIMBRINZA (Biological) $5,101
- EYLEA HD (Biological) $4,004
- XIIDRA (Drug) $466.93
- LUMIGAN (Drug) $398.51
- Rocklatan (Drug) $284.77
- Vabysmo (Drug) $279.56
- OZURDEX (Drug) $218.97
- TRAVATAN Z (Drug) $210.23
- EYLEA AFLIBERCEPT INJECTION (Biological) $159.24
- EYLEA (Biological) $152.96
- Tecnis IOL (Device) $145.02
- rocklatan (Drug) $134.98
- BEOVU (Drug) $132.30
- AcrySof (Device) $102.73
- TECNIS IOL (Device) $94.29
- VYZULTA (Drug) $91.59
- rhopressa (Drug) $76.09
- TYRVAYA (Drug) $58.75
- Lucentis (Biological) $58.34
- COMBIGAN (Drug) $49.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Ft Lauderdale
Dr. Eduardo Uchiyama, M.d, M.D
Ophthalmology — Payments: $361,047
Ophthalmology $361,047
Dr. Robert Kramm, Md, Mse, MD, MSE
Ophthalmology — Payments: $128,093
Ophthalmology $128,093
Dr. Mario Del Cid, Md, MD
Ophthalmology — Payments: $14,565
Ophthalmology $14,565
Barry Taney, Md, MD
Ophthalmology — Payments: $11,060
Ophthalmology $11,060
Lawrence Halperin, Md, MD
Ophthalmology — Payments: $10,765
Ophthalmology $10,765
Dr. Ryan Shields, Md, MD
Ophthalmology — Payments: $9,430
Ophthalmology $9,430